Is Blockade of Vascular Endothelial Growth Factor Beneficial for All Types of Diabetic Retinopathy?

Diabetologia - Germany
doi 10.1007/s00125-008-1078-9
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Anti-Vascular Endothelial Growth Factor for Proliferative Diabetic Retinopathy

2010English

Upregulated Expression of Vascular Endothelial Growth Factor in Proliferative Diabetic Retinopathy.

British Journal of Ophthalmology
Molecular NeuroscienceOphthalmologySensory SystemsCellular
1996English

Vascular Endothelial Growth Factor Inhibition for Proliferative Diabetic Retinopathy: Et Tu, Brute?

Acta Ophthalmologica
MedicineOphthalmology
2017English

Vascular Endothelial Growth Factor +405g/C Polymorphism as a Predictor of Diabetic Retinopathy

Bulletin of the National Research Centre
2020English

Diabetic Retinopathy Is Associated With a Switch in Splicing From Anti- To Pro-Angiogenic Isoforms of Vascular Endothelial Growth Factor

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2005English

Systemic Factors Related to Intraocular Levels of Interleukin-6 and Vascular Endothelial Growth Factor in Diabetic Retinopathy

Journal of Ophthalmology
Ophthalmology
2019English

Association Between a Vascular Endothelial Growth Factor Gene Polymorphism (Rs2146323) and Diabetic Retinopathy: A Meta-Analysis

BMC Ophthalmology
MedicineOphthalmology
2015English

Blockade of Prolymphangiogenic Vascular Endothelial Growth Factor C in Dry Eye Disease

Archives of Ophthalmology
2012English

Vascular Endothelial Growth Factor Blockade Prevents the Beneficial Effects of -Blocker Therapy on Cardiac Function, Angiogenesis, and Remodeling in Heart Failure

Circulation. Heart failure
MedicineCardiovascular MedicineCardiology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy